Oncology R&D

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Oncology R&D

Jul 19, 2024, 14:44 | Blog

"What’s Next for Immunotherapies?" by Anas Younes

Anas Younes shared a post on LinkedIn: Immunotherapies Immunotherapies "My interview with Mark Cobbold, Senior…

Jun 22, 2024, 04:45 | Blog

Susan Galbraith: I am passionate about supporting the next generation of female leaders in STEM

Susan Galbraith, Executive Vice President in Oncology R&D at AstraZeneca, shared on LinkedIn: "It was…

All: 2 Posts: 1 - 100

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023